Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Williams

Showing results (71-80 of 722) with videos related to

Pageof 73
Sort By:
JAMA|May 12, 2020
COVID-19 and Health Equity-A New Kind of "Herd Immunity"David R Williams, Lisa A Cooper
Drug Discovery Today|June 25, 2018
The inherent risks associated with newly traded biopharmaceutical firmsDavid R Williams, Trent J Spaulding
American Journal of Epidemiology|March 1, 2011
Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease?Michelle A Albert, David R Williams
Plos One|January 25, 2012
Perceived discrimination and self-rated health in South Korea: a nationally representative surveySeung-Sup Kim, David R Williams
Nature Reviews. Neurology|March 21, 2012
Diagnosis of dystonic syndromes--a new eight-question approachKelly L Bertram, David R Williams
Journal of the American Chemical Society|March 18, 2004
Carbolithiation for the generation of cyclooctadienyl anions and tandem electrocyclization/alkylation to functionalized cis-bicyclo[3.3.0]octenesDavid R Williams, Jonathan T Reeves
Journal of the American Chemical Society|October 20, 2005
1-alkoxyallene as an effective precursor for regio- and stereocontrolled allylation reactions with aliphatic aldehydes via bis-stannylationDavid R Williams, Micheal W Fultz
Journal of Health Care Finance|January 30, 2009
Trends in biopharmaceutical IPOS: 1996-2005David R Williams, Carlton C Young
The American Behavioral Scientist|December 19, 2013
Racism and Health II: A Needed Research Agenda for Effective InterventionsDavid R Williams, Selina A Mohammed
JAMA|October 12, 2020
Excess Deaths From COVID-19, Community Bereavement, and Restorative Justice for Communities of ColorLisa A Cooper, David R Williams
Pageof 73

Showing results (71-80 of 722) with videos related to

Sort By:
Pageof 73
JAMA|May 12, 2020
COVID-19 and Health Equity-A New Kind of "Herd Immunity"David R Williams, Lisa A Cooper
Drug Discovery Today|June 25, 2018
The inherent risks associated with newly traded biopharmaceutical firmsDavid R Williams, Trent J Spaulding
American Journal of Epidemiology|March 1, 2011
Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease?Michelle A Albert, David R Williams
Plos One|January 25, 2012
Perceived discrimination and self-rated health in South Korea: a nationally representative surveySeung-Sup Kim, David R Williams
Nature Reviews. Neurology|March 21, 2012
Diagnosis of dystonic syndromes--a new eight-question approachKelly L Bertram, David R Williams
Journal of the American Chemical Society|March 18, 2004
Carbolithiation for the generation of cyclooctadienyl anions and tandem electrocyclization/alkylation to functionalized cis-bicyclo[3.3.0]octenesDavid R Williams, Jonathan T Reeves
Journal of the American Chemical Society|October 20, 2005
1-alkoxyallene as an effective precursor for regio- and stereocontrolled allylation reactions with aliphatic aldehydes via bis-stannylationDavid R Williams, Micheal W Fultz
Journal of Health Care Finance|January 30, 2009
Trends in biopharmaceutical IPOS: 1996-2005David R Williams, Carlton C Young
The American Behavioral Scientist|December 19, 2013
Racism and Health II: A Needed Research Agenda for Effective InterventionsDavid R Williams, Selina A Mohammed
JAMA|October 12, 2020
Excess Deaths From COVID-19, Community Bereavement, and Restorative Justice for Communities of ColorLisa A Cooper, David R Williams
Pageof 73